Terbinafine Topical Creams /Solutions Suppliers & Bulk Manufacturers
Available Forms: Topical Creams /Solutions
Available Strengths: 1% cream, 1% solution
Reference Brands: Lamisil(US & EU)
Category: Anti-fungal
Terbinafine inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and damaging fungal cell membranes. It effectively treats dermatophyte skin infections with rapid relief, broad antifungal activity, and minimal side effects. Topical formulations provide targeted therapy for skin infections, ensuring effective, localized treatment with safety and convenience. Terbinafine Topical Creams /Solutions is available in Topical Creams /Solutions and strengths such as 1% cream, 1% solution. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Terbinafine Topical Creams /Solutions is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Terbinafine Topical Creams /Solutions can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Terbinafine topical creams and solutions are approved in the EU and US for treating dermatophyte skin infections. In the EU, brands like Lamisil are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA-approved terbinafine topical products, such as Lamisil, are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and continuous safety monitoring. For expert assistance with regulatory submissions, dossiers, and compliance, visit PharmaTradz. We support efficient market entry for terbinafine topical formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Terbinafine is used to treat fungal infections of the skin, hair, and nails, such as athlete’s foot, ringworm, jock itch, and onychomycosis (nail fungus). It works by inhibiting the enzyme squalene epoxidase, which is essential for fungal cell membrane synthesis, leading to the death of the fungal cells.
Terbinafine is a synthetic allylamine antifungal compound chemically derived from naphthalene and allylamine structures. It is formulated as Terbinafine Hydrochloride in tablets, creams, gels, sprays, and oral granules.
Common trade names include Lamisil, Terbinex, and Zimig.
The original brand Lamisil was developed and marketed by Novartis. Several other pharmaceutical companies now produce generic versions worldwide, including Sun Pharma, Sandoz, and Teva.
The generic name is Terbinafine (usually in the form of Terbinafine Hydrochloride).
The brand names include Lamisil, Terbinex, and Zimig.
Terbinafine is manufactured globally by various pharmaceutical companies, including facilities in Switzerland, India, the USA, and the UK, under brands and generics by Novartis, Sandoz, and Sun Pharma.
Related Products
Naftifine Hydrochloride
Strength:
1 %, 2%
Form: Cream / Gel
Reference Brands: Naftin (USA), Xolafin (USA)
View Details
Sertaconazole Nitrate
Strength:
2 %
Form: Creams
Reference Brands: Ertaczo (USA), Zalain (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
